| scholarly article | Q13442814 |
| P356 | DOI | 10.1097/00003086-200007000-00038 |
| P698 | PubMed publication ID | 10906887 |
| P50 | author | Joel A Block | Q63819762 |
| P2093 | author name string | Z Qi | |
| K R Berend | |||
| S P Scully | |||
| A Toth | |||
| W N Qi | |||
| P4510 | describes a project that uses | 105KC | Q54399871 |
| FSCP-1 | Q54835202 | ||
| JJ012 | Q54898950 | ||
| P433 | issue | 376 | |
| P407 | language of work or name | English | Q1860 |
| P921 | main subject | cell line | Q21014462 |
| chondrosarcoma | Q1076087 | ||
| P304 | page(s) | 291-303 | |
| P577 | publication date | 2000-07-01 | |
| P1433 | published in | Clinical Orthopaedics and Related Research | Q5133783 |
| P1476 | title | Marshall Urist Award. Interstitial collagenase gene expression correlates with in vitro invasion in human chondrosarcoma |
| Q36538450 | 1-benzyl-2-phenylbenzimidazole (BPB), a benzimidazole derivative, induces cell apoptosis in human chondrosarcoma through intrinsic and extrinsic pathways |
| Q42060251 | A neural network model for cell classification based on single-cell biomechanical properties |
| Q91938750 | A screening-based approach identifies cell cycle regulators AURKA, CHK1 and PLK1 as targetable regulators of chondrosarcoma cell survival |
| Q35632931 | A thin-layer model for viscoelastic, stress-relaxation testing of cells using atomic force microscopy: do cell properties reflect metastatic potential? |
| Q34109859 | Activation of the proteolytic activity of ADAMTS4 (aggrecanase-1) by C-terminal truncation |
| Q38946440 | An orthotopic mouse model for chondrosarcoma of bone provides an in vivo tool for drug testing |
| Q28544902 | BMP-7 enhances cell migration and αvβ3 integrin expression via a c-Src-dependent pathway in human chondrosarcoma cells |
| Q58705635 | Bcl-xl as the most promising Bcl-2 family member in targeted treatment of chondrosarcoma |
| Q61807296 | Exploration of the chondrosarcoma metabolome; the mTOR pathway as an important pro-survival pathway |
| Q34548365 | HGF and c-Met interaction promotes migration in human chondrosarcoma cells |
| Q90642318 | Heterogeneity of chondrosarcomas response to irradiations with X-rays and carbon ions: A comparative study on five cell lines |
| Q37627264 | High density micromass cultures of a human chondrocyte cell line: a reliable assay system to reveal the modulatory functions of pharmacological agents. |
| Q38696894 | Identification of an easy to use 3D culture model to investigate invasion and anticancer drug response in chondrosarcomas |
| Q91761588 | Inhibition of PARP Sensitizes Chondrosarcoma Cell Lines to Chemo- and Radiotherapy Irrespective of the IDH1 or IDH2 Mutation Status |
| Q38884358 | Inhibition of mutant IDH1 decreases D-2-HG levels without affecting tumorigenic properties of chondrosarcoma cell lines. |
| Q27315973 | Matrix metalloproteinase 1: role in sarcoma biology |
| Q39498514 | Matrix metalloproteinase-1 contribution to sarcoma cell invasion |
| Q39963494 | Myc-oncogene inactivating effect by proline rich polypeptide (PRP-1) in chondrosarcoma JJ012 cells |
| Q33986627 | New clinically relevant, orthotopic mouse models of human chondrosarcoma with spontaneous metastasis |
| Q64972730 | Radiotherapy resistance in chondrosarcoma cells; a possible correlation with alterations in cell cycle related genes. |
| Q36190010 | Somatic mosaic IDH1 and IDH2 mutations are associated with enchondroma and spindle cell hemangioma in Ollier disease and Maffucci syndrome |
| Q37185828 | Src kinases in chondrosarcoma chemoresistance and migration: dasatinib sensitises to doxorubicin in TP53 mutant cells |
| Q88167587 | Targeting glutaminolysis in chondrosarcoma in context of the IDH1/2 mutation |
| Q42419178 | Targeting survivin as a potential new treatment for chondrosarcoma of bone |
| Q36596143 | The potential for isocitrate dehydrogenase mutations to produce 2-hydroxyglutarate depends on allele specificity and subcellular compartmentalization. |
| Q34396287 | Three new chondrosarcoma cell lines: one grade III conventional central chondrosarcoma and two dedifferentiated chondrosarcomas of bone |
| Q35774484 | Treatment with a Small Molecule Mutant IDH1 Inhibitor Suppresses Tumorigenic Activity and Decreases Production of the Oncometabolite 2-Hydroxyglutarate in Human Chondrosarcoma Cells |
| Q35125621 | Updates on the cytogenetics and molecular genetics of bone and soft tissue tumors: chondrosarcoma and other cartilaginous neoplasms |
| Q39850934 | siRNA-based targeting of antiapoptotic genes can reverse chemoresistance in P-glycoprotein expressing chondrosarcoma cells |
Search more.